Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: mc who wrote (5654)	9/23/1998 10:56:00 PM
From: Bradpalm1	Read Replies (1) \| Respond to of 7041

<<It seems to me that if the contraindications noted in the PDR hold up that the Vasomax contraindications could actually be worse than Viagra's because it would include all people who have suffered myocardial infarction, not just those being treated with nitrates.>> I agree, Gary. Approximately 30-50% cardiac patients are on some form of nitrates, depending on their precise cardiac status and condition. Oral phentolamine will have a rough time making it through the FDA based given its known intrinsic pharmacological activity in cardiac patients. Bradpalm1